The 'co-delivery' approach to liposomal vaccines: Application to the development of influenza-A and hepatitis-B vaccine candidates

Journal of Liposome Research

Volumn 16, Issue 3, 2006, Pages 229-235

  Laing, Peter ^a   Bacon, Andrew ^a   McCormack, Brenda ^a   Gregoriadis, Gregory ^a,b   Frisch, Benoît ^c   Schuber, Francis ^c  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c CNRS   (France)

Author keywords

DNA vaccination; Hepatitis B; Influenza A; Liposomal vaccine

Indexed keywords

ENGERIX; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIPOSOME; PLASMID DNA; VIRUS ANTIGEN;

ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG POTENTIATION; IMMUNE RESPONSE; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRION;

HEPATITIS B VACCINES; HUMANS; INFLUENZA VACCINES; LIPOSOMES;

EID: 33748483244     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100600880432     Document Type: Conference Paper

References (14)

1. Bacon, A., Caparrós-Wanderley, W., Zadi, B., Gregoriadis, G. (2002). Induction of a cytotoxic T lymphocyte (CTL) response to plasmid DNA delivered by Lipodine, J. Liposome Research 12:173-183.
2. Bacon, A., Hreczuk-Hirst, D.H., McCormack, B., Caparros-Wanderley, W., Epenetos, A., Laing, P., Gregoriadis, G. (2003). In: Proceedings of 30th Annual Meeting of the Controlled Release Society, Abstract 441, p 884.
3. Davis, H. L., Whalen, R. G., Demeneix, B. A. (1993). Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther., 4:151-159.
4. Espuelas, S., Haller, P., Schuber, F., Frisch, B. (2003). Synthesis of an amphiplilic tetraantennary mannosyl conjugate and incorporation into liposome carriers, Bioorg. Med. Chem. Lett. 13:2557-2560.
5. Garcon, N., Gregoriadis, G., Taylor, M., Summerfield, J. (1988). Targeted immunoadjuvant action of tetanus toxoid-containing liposomes coated with mannosylated albumin, Immunology, 64:743-745.
6. Gregoriadis, G. (1998). Genetic vaccines: Strategies for optimization, Pharmaceutical Research 15:661-670.
7. rd Edition, (ed. G. Gregoriadis) NY, in press.
8. Gregoriadis, G., Saffie, R., de Souza, J. B. (1997). Liposome-mediated DNA vaccination. FEBS Lett. 402:107-110.
9. Gregoriadis, G., Saffie, R., Hart, S. L. (1996). High yield incorporation of plasmid DNA within liposomes: Effect on DNA integrity and transfection efficiency. J. Drug Targeting 3:469-475.
10. Lewis, P. J., Babiuk, L. A. (1999). DNA vaccines: a review. Adv. Virus Res. 54:129-188.
11. Perrie, Y., Frederik, P. M., Gregoriadis, G. (2001). Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 19:3301-3310.
12. Perrie, Y., Gregoriadis, G. (2000). Liposome-entrapped plasmid DNA: Characterization studies. Biochim. Biophys. Acta 1475:125-132.
13. Perrie, Y., Obrenovic, M., D. McCarthy, D., G. Gregoriadis, G. (2002). Liposome (LipodineJ)-mediated DNA vaccination by the oral route. J. Liposome Res. 12:185-197.
14. Zadi, B., Gregoriadis, G. (2000). A novel method for high-yield entrapment of solutes into small liposomes J. Liposome Res., 10:73-80.